title: [Cycloplatin (LACHEMA) in ovarian carcinoma. Results of a registered study].
abstract: A short report is given on the first results of the Carboplatin registration trial in ovarian cancer. CR 3/10 pat. PR 4/10 pat. remission time 10 ms in average. In comparison with cisplatin the efficacy is similar. The side effects are different particularly the bone marrow was more affected in contrast to cisplatin. The nephrotoxic side effects can be neglected.
authors.affiliation: Arbeitsgemeinschaft Gynäkologische Onkologie, Gesellschaft für Gynäkologie und Geburtshilfe, Erfurt, Bundesrepublik Deutschland.
authors.forename: W
authors.initials: W
authors.lastname: Krafft
authors.forename: U
authors.initials: U
authors.lastname: Müller
authors.forename: J
authors.initials: J
authors.lastname: Hoffmann
authors.forename: H
authors.initials: H
authors.lastname: Nöschel
authors.forename: J
authors.initials: J
authors.lastname: Schloser
authors.forename: E M
authors.initials: EM
authors.lastname: König
authors.forename: R
authors.initials: R
authors.lastname: Lorenz
mesh_terms: D000328:Adult; D000368:Aged; D016190:Carboplatin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D016190:Carboplatin
vernacular_title: Cycloplatin (LACHEMA) beim Ovarialkarzinom. Ergebnisse einer Registrierungsstudie.